Shilpa Medicare Ltd (SHILPAMED) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Shilpa Medicare Ltd reported sales of ₹466 Cr, operating profit of ₹136 Cr (OPM 29%) and net profit of ₹101 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
SHILPAMED quarterly results (₹ Cr) Metric Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sales 344 319 331 321 370 410 437 466 Expenses 258 239 252 231 262 296 317 330 Operating Profit 86 81 79 91 108 114 120 136 OPM 25% 25% 24% 28% 29% 28% 27% 29% Other Income 5 2 -21 6 2 -13 45 9 Interest 26 12 14 19 16 11 14 12 Depreciation 28 29 29 29 30 30 31 35 Profit before tax 37 42 15 50 64 61 120 98 Tax 51% 24% 5% 5% 32% 27% 10% -3% Net Profit 18 32 15 47 44 45 108 101 EPS in Rs 0.92 1.62 0.74 2.4 2.25 2.28 5.51 5.16
SHILPAMED profit & loss, annual (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM Sales 1,141 1,046 1,146 1,281 1,535 1,683 Expenses 940 947 907 962 1,100 1,204 Operating Profit 202 99 239 319 435 479 OPM 18% 9% 21% 25% 28% 28% Other Income 21 17 15 -8 39 43 Interest 41 59 92 76 59 52 Depreciation 80 96 108 113 120 126 Profit before tax 102 -38 54 122 295 344 Tax 41% -19% 41% 36% 18% - Net Profit 61 -31 32 78 243 297 EPS in Rs 3.49 -1.87 1.84 4 12.44 15.2 Dividend Payout 16% 0% 0% 12% 5% -
SHILPAMED balance sheet (₹ Cr) Metric Mar 2023 Mar 2024 Mar 2025 Sep 2025 Mar 2026 Equity Capital 9 9 10 10 20 Reserves 1,775 1,800 2,353 2,427 2,572 Borrowings 798 937 588 593 660 Other Liabilities 323 347 360 465 455 Total Liabilities 2,904 3,093 3,311 3,495 3,706 Fixed Assets 1,368 1,385 1,418 1,801 1,593 CWIP 655 719 822 534 884 Investments 43 40 35 32 58 Other Assets 838 950 1,037 1,128 1,170 Total Assets 2,904 3,093 3,311 3,495 3,706
SHILPAMED cash flows (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity 105 180 137 132 342 Cash from Investing Activity -286 -232 -171 -198 -339 Cash from Financing Activity 83 46 47 63 14 Net Cash Flow -98 -7 13 -3 17 Free Cash Flow -226 -46 -48 -111 -28 CFO/OP 69% 215% 74% 56% 93%
SHILPAMED ratios Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Debtor Days 124 113 125 126 123 Inventory Days 338 280 309 309 291 Days Payable 139 125 156 93 113 Cash Conversion Cycle 323 268 278 342 301 Working Capital Days 77 -13 48 80 51 ROCE 6% 1% 5% 8% 11%